Trupanion, Inc. (NASDAQ:TRUP) Receives $41.60 Consensus Price Target from Brokerages

Trupanion, Inc. (NASDAQ:TRUP) has received a consensus rating of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $41.60.

TRUP has been the subject of several research analyst reports. Weiss Ratings upgraded Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday. Atlantic Securities set a $42.00 price objective on Trupanion in a research note on Wednesday, July 15th. Zacks Research raised shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 24th. Finally, Stifel Nicolaus set a $28.00 target price on shares of Trupanion in a research report on Friday, June 26th.

Trupanion Stock Performance

TRUP stock opened at $30.60 on Monday. The company has a market cap of $1.34 billion, a price-to-earnings ratio of 57.74, a PEG ratio of 2.20 and a beta of 1.39. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The business has a fifty day simple moving average of $25.56 and a 200-day simple moving average of $26.06. Trupanion has a 52 week low of $21.16 and a 52 week high of $49.90.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The business had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. During the same period last year, the company posted $0.22 EPS. The business’s quarterly revenue was up 11.1% on a year-over-year basis. On average, equities research analysts expect that Trupanion will post 0.59 EPS for the current year.

Insider Buying and Selling at Trupanion

In other news, CEO Margaret Tooth sold 978 shares of the firm’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total value of $28,410.90. Following the transaction, the chief executive officer owned 175,401 shares of the company’s stock, valued at approximately $5,095,399.05. This trade represents a 0.55% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Steve Weinrauch sold 6,674 shares of Trupanion stock in a transaction on Friday, June 5th. The shares were sold at an average price of $22.00, for a total transaction of $146,828.00. Following the transaction, the executive vice president owned 78,062 shares in the company, valued at $1,717,364. The trade was a 7.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 18,785 shares of company stock valued at $422,862 in the last ninety days. Corporate insiders own 5.58% of the company’s stock.

Institutional Trading of Trupanion

Several large investors have recently added to or reduced their stakes in TRUP. Kelleher Financial Advisors purchased a new position in Trupanion in the second quarter valued at about $42,000. Kemnay Advisory Services Inc. purchased a new stake in shares of Trupanion in the fourth quarter worth about $64,000. Parallel Advisors LLC boosted its position in shares of Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after buying an additional 1,722 shares during the period. Quantbot Technologies LP acquired a new stake in shares of Trupanion in the second quarter valued at about $89,000. Finally, Advisory Services Network LLC acquired a new stake in shares of Trupanion in the third quarter valued at about $160,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.